Commerzbank Aktiengesellschaft’s Foundation Medicine, Inc. FMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-11,000
Closed -$437K 828
2017
Q2
$437K Sell
11,000
-360
-3% -$13.2K 0.01% 545
2017
Q1
$366K Sell
11,360
-132
-1% -$3.29K 0.01% 734
2016
Q4
$203K Buy
11,492
+93
+0.8% +$2K ﹤0.01% 899
2016
Q3
$266K Hold
11,399
﹤0.01% 760
2016
Q2
$213 Sell
11,399
-723
-6% -$13.1K ﹤0.01% 920
2016
Q1
$220K Buy
12,122
+723
+6% +$11.6K ﹤0.01% 947
2015
Q4
$240K Buy
11,399
+165
+1% +$3.18K ﹤0.01% 1039
2015
Q3
$207K Hold
11,234
﹤0.01% 1041
2015
Q2
$380K Sell
11,234
-101
-0.9% -$4.06K ﹤0.01% 1040
2015
Q1
$545K Sell
11,335
-654
-5% -$29.7K ﹤0.01% 931
2014
Q4
$266K Buy
11,989
+782
+7% +$18K ﹤0.01% 1091
2014
Q3
$213K Buy
11,207
+207
+2% +$4.94K ﹤0.01% 1077
2014
Q2
$297K Hold
11,000
﹤0.01% 1089
2014
Q1
$356K Buy
+11,000
New +$357K ﹤0.01% 1058

Other funds holding FMI

Commerzbank Aktiengesellschaft's FMI Position: Q3 2017 in Review

Commerzbank Aktiengesellschaft sold out of Foundation Medicine, Inc. (FMI) in Q3 2017, closing a stake of 11,000 shares — an estimated $437K sold.

Commerzbank Aktiengesellschaft first reported a position in FMI in Q1 2014 and held it in 14 quarters. The position peaked at $545K in Q1 2015. 97 funds tracked by Wall St. Rank hold FMI as of Q3 2017.

  • Commerzbank Aktiengesellschaft reported no remaining Foundation Medicine, Inc. position as of Q3 2017 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 11,000 Foundation Medicine, Inc. shares in Q3 2017, an estimated $437K.
  • Commerzbank Aktiengesellschaft first reported a position in Foundation Medicine, Inc. in Q1 2014 and held it in 14 quarters.
  • Commerzbank Aktiengesellschaft's Foundation Medicine, Inc. position peaked at $545K in Q1 2015.
  • 97 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2017.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q3 2017, filed 13 Nov 2017.